Global Fetal Bovine Serum for Cell Culture Media Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fetal Bovine Serum for Cell Culture Media Market Insights, Forecast to 2034
Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS
Global Fetal Bovine Serum for Cell Culture Media market is expected to reach to US$ 702 million in 2024, with a positive growth of %, compared with US$ 675 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fetal Bovine Serum for Cell Culture Media industry is evaluated to reach US$ 868 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Covers
This report presents an overview of global Fetal Bovine Serum for Cell Culture Media market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Fetal Bovine Serum for Cell Culture Media market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Academic Research
Commercial Research
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fetal Bovine Serum for Cell Culture Media plant distribution, commercial date of Fetal Bovine Serum for Cell Culture Media, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fetal Bovine Serum for Cell Culture Media introduction, etc. Fetal Bovine Serum for Cell Culture Media Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Fetal Bovine Serum for Cell Culture Media
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Fetal Bovine Serum for Cell Culture Media market is expected to reach to US$ 702 million in 2024, with a positive growth of %, compared with US$ 675 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Fetal Bovine Serum for Cell Culture Media industry is evaluated to reach US$ 868 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The animal serum product market is primarily driven by its extensive use in various applications, including cell culture, biopharmaceutical production, and diagnostics. Fetal bovine serum (FBS) and other animal-derived sera contain essential nutrients and growth factors necessary for cell growth and viability, making them indispensable in research and industrial processes. Moreover, the increasing demand for biologics and personalized medicine fuels the need for high-quality animal serum products to support cell-based therapies and recombinant protein production. However, the market also faces challenges, notably concerns about ethical considerations and the risk of contaminations associated with animal-derived products. There is a growing push towards animal-free and defined media alternatives to address these challenges. Additionally, the variability in serum composition from different sources and batches poses a challenge in ensuring consistent and reproducible results in cell-based research and biomanufacturing.
Report Covers
This report presents an overview of global Fetal Bovine Serum for Cell Culture Media market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Fetal Bovine Serum for Cell Culture Media market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Cytiva
Merck
Moregate BioTech
Gemini
R&D Systems
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others
Segment by Application
Academic Research
Commercial Research
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Fetal Bovine Serum for Cell Culture Media plant distribution, commercial date of Fetal Bovine Serum for Cell Culture Media, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Fetal Bovine Serum for Cell Culture Media introduction, etc. Fetal Bovine Serum for Cell Culture Media Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Fetal Bovine Serum for Cell Culture Media
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports